NR3C1 and cancer: In vitro and in vivo experiments suggest that activation of the GR in ER-negative pre-malignant breast epithelial and cancer cells initiates cell survival pathways under otherwise apoptosis-inducing conditions (e.g. chemotherapy, radiation, and growth factor deprivation) (Wu et al. 2004).